Sale!

CSF1R Gene Leukoencephalopathy diffuse hereditary with spheroids Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CSF1R Gene Leukoencephalopathy Diffuse Hereditary with Spheroids Genetic Test” is a specialized diagnostic assessment performed to identify mutations in the CSF1R gene, which are linked to a rare neurological condition known as Leukoencephalopathy with Diffuse Hereditary Spheroids (HDLS). This disorder is characterized by a progressive deterioration of white matter in the brain, leading to a wide range of neurological symptoms such as memory loss, personality changes, and motor skill decline. Early detection through genetic testing is crucial for managing the condition and potentially slowing its progression through targeted therapies. The test is available at DNA Labs UAE, a leading facility in genetic diagnostics, at a cost of 4400 AED. This test is vital for individuals with a family history of the disorder or those exhibiting symptoms, providing them with crucial information for managing their health.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CSF1R Gene Leukoencephalopathy Diffuse Hereditary with Spheroids Genetic Test

Are you or your loved one experiencing progressive neurological symptoms? DNA Labs UAE offers the CSF1R Gene Leukoencephalopathy Diffuse Hereditary with Spheroids Genetic Test, a comprehensive genetic test for individuals suspected to have this rare genetic disorder.

Test Details

CSF1R gene leukoencephalopathy, diffuse hereditary, with spheroids is a rare genetic disorder that affects the white matter of the brain. It is characterized by the presence of abnormal protein deposits called spheroids, which can cause progressive neurological symptoms.

NGS genetic testing refers to Next-Generation Sequencing, a high-throughput DNA sequencing technology. This type of genetic test can analyze multiple genes simultaneously, including the CSF1R gene, to identify any mutations or variations that may be associated with leukoencephalopathy with spheroids.

By performing NGS genetic testing, healthcare professionals can determine if a person carries any genetic variants in the CSF1R gene that may be responsible for the development of this condition. This information can be used for diagnosis, genetic counseling, and potentially guiding treatment decisions.

It is important to note that genetic testing for CSF1R gene leukoencephalopathy is typically ordered by a healthcare professional who specializes in genetics or neurology. They will assess the individual’s symptoms, medical history, and family history before determining if genetic testing is appropriate.

Test Components and Price

  • Test Name: CSF1R Gene Leukoencephalopathy Diffuse Hereditary with Spheroids Genetic Test
  • Components: NGS Technology
  • Price: 4400.0 AED

Sample Condition and Report Delivery

The sample required for this genetic test can be either blood, extracted DNA, or one drop of blood on an FTA card. The report delivery time is approximately 3 to 4 weeks.

Test Type and Doctor

This genetic test falls under the category of Neurological Disorders. It is recommended to consult a Neurologist for further guidance and interpretation of the test results.

Test Department and Pre Test Information

This genetic test is conducted by the Genetics department. Before undergoing the CSF1R Gene Leukoencephalopathy Diffuse Hereditary with Spheroids Genetic Test, it is important to provide a clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with CSF1R Gene Leukoencephalopathy, diffuse hereditary, with spheroids.

Conclusion

With the CSF1R Gene Leukoencephalopathy Diffuse Hereditary with Spheroids Genetic Test offered by DNA Labs UAE, individuals suspected to have this rare genetic disorder can receive accurate diagnosis, genetic counseling, and potentially guide treatment decisions. By analyzing the CSF1R gene using NGS technology, healthcare professionals can identify any mutations or variations associated with leukoencephalopathy with spheroids. Consult a healthcare professional specializing in genetics or neurology to determine if this test is appropriate for you or your loved one.

Test Name CSF1R Gene Leukoencephalopathy diffuse hereditary with spheroids Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CSF1R Gene Leukoencephalopathy, diffuse hereditary, with spheroids NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CSF1R Gene Leukoencephalopathy, diffuse hereditary, with spheroids
Test Details

CSF1R gene leukoencephalopathy, diffuse hereditary, with spheroids is a rare genetic disorder that affects the white matter of the brain. It is characterized by the presence of abnormal protein deposits called spheroids, which can cause progressive neurological symptoms.

NGS genetic testing refers to Next-Generation Sequencing, a high-throughput DNA sequencing technology. This type of genetic test can analyze multiple genes simultaneously, including the CSF1R gene, to identify any mutations or variations that may be associated with leukoencephalopathy with spheroids.

By performing NGS genetic testing, healthcare professionals can determine if a person carries any genetic variants in the CSF1R gene that may be responsible for the development of this condition. This information can be used for diagnosis, genetic counseling, and potentially guiding treatment decisions.

It is important to note that genetic testing for CSF1R gene leukoencephalopathy is typically ordered by a healthcare professional who specializes in genetics or neurology. They will assess the individual’s symptoms, medical history, and family history before determining if genetic testing is appropriate.